TrialThe American journal of gastroenterology2020

Efficacy of Tenapanor in Treating Patients With Irritable Bowel Syndrome With Constipation: A 12-Week, Placebo-Controlled Phase 3 Trial (T3MPO-1).

William D Chey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.